Brimonidine/Timolol: a viewpoint by Robert M. Feldman.
Feldman
Robert M
RM
Department of Ophthalmology and Visual Science, The University of Texas-Houston, Houston, TX, USA.
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D004359:Drug Therapy, Combination; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects* / Q000737:chemistry; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D013999:Timolol